Shanghai VKEY Biotechnologies Co.,Ltd. has developed Protein-protein Interaction assay service platforms based on NanoBRET technology. These platforms enable customers to evaluate cell-based drug activity, whether activating or inhibiting PPI, and also offer customized development services.